197 related articles for article (PubMed ID: 21765641)
1. Mucosal immunization induces a higher level of lasting neutralizing antibody response in mice by a replication-competent smallpox vaccine: vaccinia Tiantan strain.
Lu B; Yu W; Huang X; Wang H; Liu L; Chen Z
J Biomed Biotechnol; 2011; 2011():970424. PubMed ID: 21765641
[TBL] [Abstract][Full Text] [Related]
2. One time intranasal vaccination with a modified vaccinia Tiantan strain MVTT(ZCI) protects animals against pathogenic viral challenge.
Yu W; Fang Q; Zhu W; Wang H; Tien P; Zhang L; Chen Z
Vaccine; 2010 Feb; 28(9):2088-96. PubMed ID: 20045097
[TBL] [Abstract][Full Text] [Related]
3. A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination.
Huang X; Lu B; Yu W; Fang Q; Liu L; Zhuang K; Shen T; Wang H; Tian P; Zhang L; Chen Z
PLoS One; 2009; 4(1):e4180. PubMed ID: 19159014
[TBL] [Abstract][Full Text] [Related]
4. A novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in China.
Liu Q; Huang W; Nie J; Zhu R; Gao D; Song A; Meng S; Xu X; Wang Y
PLoS One; 2012; 7(3):e33392. PubMed ID: 22438922
[TBL] [Abstract][Full Text] [Related]
5. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: mucosal application of a lyophilized viral vector vaccine confers systemic and protective immunity toward intracellular pathogens.
Kastenmuller W; Gasteiger G; Stross L; Busch DH; Drexler I
J Immunol; 2009 Mar; 182(5):2573-7. PubMed ID: 19234150
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens.
Sakhatskyy P; Wang S; Zhang C; Chou TH; Kishko M; Lu S
Virology; 2008 Feb; 371(1):98-107. PubMed ID: 17950773
[TBL] [Abstract][Full Text] [Related]
8. Comparative Efficacy of Intramuscular and Scarification Routes of Administration of Live Smallpox Vaccine in a Murine Challenge Model.
Phelps A; Gates AJ; Eastaugh L; Hillier M; Ulaeto DO
Vaccine; 2017 Jul; 35(31):3889-3896. PubMed ID: 28606813
[TBL] [Abstract][Full Text] [Related]
9. Oral immunization against smallpox.
Hochstein-Mintzel V; Stickl H; Huber HC
Dev Biol Stand; 1976; 33():260-6. PubMed ID: 182585
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
[TBL] [Abstract][Full Text] [Related]
11. Protection of mice against the highly pathogenic VV
Bissa M; Quaglino E; Zanotto C; Illiano E; Rolih V; Pacchioni S; Cavallo F; De Giuli Morghen C; Radaelli A
Antiviral Res; 2016 Oct; 134():182-191. PubMed ID: 27637905
[TBL] [Abstract][Full Text] [Related]
12. Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.
Meseda CA; Campbell J; Kumar A; Garcia AD; Merchlinsky M; Weir JP
PLoS One; 2013; 8(6):e67984. PubMed ID: 23785523
[TBL] [Abstract][Full Text] [Related]
13. Capturing the natural diversity of the human antibody response against vaccinia virus.
Lantto J; Haahr Hansen M; Rasmussen SK; Steinaa L; Poulsen TR; Duggan J; Dennis M; Naylor I; Easterbrook L; Bregenholt S; Haurum J; Jensen A
J Virol; 2011 Feb; 85(4):1820-33. PubMed ID: 21147924
[TBL] [Abstract][Full Text] [Related]
14. E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
Volz A; Jany S; Freudenstein A; Lantermann M; Ludwig H; Sutter G
Viruses; 2018 Jan; 10(1):. PubMed ID: 29300297
[TBL] [Abstract][Full Text] [Related]
15. Selection of Vaccinia Virus-Neutralizing Antibody from a Phage-Display Human-Antibody Library.
Shin YW; Chang KH; Hong GW; Yeo SG; Jee Y; Kim JH; Oh MD; Cho DH; Kim SH
J Microbiol Biotechnol; 2019 Apr; 29(4):651-657. PubMed ID: 30856707
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario.
Frey SE; Winokur PL; Salata RA; El-Kamary SS; Turley CB; Walter EB; Hay CM; Newman FK; Hill HR; Zhang Y; Chaplin P; Tary-Lehmann M; Belshe RB
Vaccine; 2013 Jun; 31(29):3025-33. PubMed ID: 23664987
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.
Kennedy JS; Gurwith M; Dekker CL; Frey SE; Edwards KM; Kenner J; Lock M; Empig C; Morikawa S; Saijo M; Yokote H; Karem K; Damon I; Perlroth M; Greenberg RN
J Infect Dis; 2011 Nov; 204(9):1395-402. PubMed ID: 21921208
[TBL] [Abstract][Full Text] [Related]
18. Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response.
Pittman PR; Garman PM; Kim SH; Schmader TJ; Nieding WJ; Pike JG; Knight R; Johnston SC; Huggins JW; Kortepeter MG; Korman L; Ranadive M; Quinn X; Meyers MS
Vaccine; 2015 Jun; 33(26):2990-6. PubMed ID: 25930115
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge.
Martínez O; Bravo Cruz A; Santos S; Ramírez M; Miranda E; Shisler J; Otero M
Vaccine; 2017 Oct; 35(44):6007-6014. PubMed ID: 28629922
[TBL] [Abstract][Full Text] [Related]
20. Vaccinia virus strain LC16m8 defective in the B5R gene keeps strong protection comparable to its parental strain Lister in immunodeficient mice.
Yokote H; Shinmura Y; Kanehara T; Maruno S; Kuranaga M; Matsui H; Hashizume S
Vaccine; 2015 Nov; 33(45):6112-9. PubMed ID: 26241947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]